| 2025 |
Orang, A., Warnock, N. I., Migault, M., Dredge, B. K., Bert, A. G., Bracken, J. M., . . . Bracken, C. P. (2025). Chasing non-existent "microRNAs" in cancer. Oncogenesis, 14(1, article no. 10), 10-1-10-9. DOI Scopus4 WoS4 Europe PMC4 |
| 2025 |
Toubia, J., Kusay, Y., Maqsood, M., Warnock, N. I., Lawrence, D. M., Bracken, C. P., . . . Schreiber, A. W. (2025). TRanscriptome ANalysis of StratifiEd CohorTs (TRANSECT) enables automated assessment of global gene regulation linked to disparate expression in user defined genes and gene sets. NAR Genomics and Bioinformatics, 7(2), lqaf041-1-lqaf041-13. DOI |
| 2025 |
Nazki, F. H., & Bracken, C. P. (2025). Regulation and dysregulation of microRNA - transcription factor axes in differentiation and neuroblastoma. Cellular And Molecular Life Sciences, 82(1, article no. 304), 1-16. DOI |
| 2025 |
Kachooei, S. A., Bracken, J. M., Pillman, K. A., Gregory, P. A., & Bracken, C. P. (2025). Half of annotated human microRNAs are expressed at levels of questionable biological significance. Iscience, 28(9), 14 pages. DOI |
| 2024 |
Neumann, D. P., Phillips, C. A., Lumb, R., Palethorpe, H. M., Ramani, Y., Hollier, B. G., . . . Gregory, P. A. (2024). Quaking isoforms cooperate to promote the mesenchymal phenotype. Molecular biology of the cell, 35(2), ar17-1-ar17-12. DOI Scopus3 WoS2 Europe PMC2 |
| 2024 |
Neumann, D. P., Pillman, K. A., Dredge, B. K., Bert, A. G., Phillips, C. A., Lumb, R., . . . Gregory, P. A. (2024). The landscape of alternative polyadenylation during EMT and its regulation by the RNA-binding protein Quaking. RNA Biology, 21(1), 1-11. DOI Scopus8 WoS7 Europe PMC24 |
| 2024 |
Bracken, C. P., Goodall, G. J., & Gregory, P. A. (2024). RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer. Seminars in Cancer Biology, 102-103, 4-16. DOI Scopus20 WoS21 Europe PMC19 |
| 2024 |
Bracken, C. P., Goodall, G. J., & Gregory, P. A. (2024). Erratum to “RNA regulatory mechanisms controlling TGF-β signaling and EMT in cancer” [Semin. Cancer Biol. 102–103 (2024) 4–16, (S1044579X24000439), (10.1016/j.semcancer.2024.06.001)]. Seminars in Cancer Biology, 106-107, 13-14. DOI Scopus1 Europe PMC2 |
| 2023 |
Bracken, C. P. (2023). "Crowd-control" by RNA: a pervasive theme in biology. RNA (New York, N.Y.), 29(7), 885-888. DOI Scopus6 WoS5 Europe PMC7 |
| 2023 |
Sapkota, S., Pillman, K. A., Dredge, B. K., Liu, D., Bracken, J. M., Kachooei, S. A., . . . Goodall, G. J. (2023). On the rules of engagement for microRNAs targeting protein coding regions. Nucleic Acids Research, 51(18), 9938-9951. DOI Scopus12 WoS12 Europe PMC12 |
| 2023 |
Orang, A., Dredge, B. K., Liu, C. Y., Bracken, J. M., Chen, C. -H., Sourdin, L., . . . Bracken, C. P. (2023). Basonuclin-2 regulates extracellular matrix production and degradation. Life Science Alliance, 6(10), e202301984-1-e202301984-17. DOI Scopus3 WoS3 Europe PMC8 |
| 2022 |
Bracken, C. P., & Goodall, G. J. (2022). The many regulators of epithelial−mesenchymal transition. Nature Reviews Molecular Cell Biology, 23(2), 89-90. DOI Scopus58 WoS55 Europe PMC49 |
| 2022 |
Migault, M., Sapkota, S., & Bracken, C. P. (2022). Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators?. Cellular and Molecular Life Sciences, 79(3), 182. DOI Scopus32 WoS33 Europe PMC27 |
| 2021 |
Pham, V. V. H., Liu, L., Bracken, C., Goodall, G., Li, J., & Le, T. D. (2021). Computational methods for cancer driver discovery: A survey. Theranostics, 11(11), 5553-5568. DOI Scopus22 WoS21 Europe PMC13 |
| 2021 |
Pham, V. V. H., Liu, L., Bracken, C. P., Nguyen, T., Goodall, G. J., Li, J., & Le, T. D. (2021). pDriver: a novel method for unravelling personalized coding and miRNA cancer drivers. Bioinformatics, 37(19), 3285-3292. DOI Scopus13 WoS13 Europe PMC10 |
| 2021 |
Prompsy, P. B., Toubia, J., Gearing, L. J., Knight, R. L., Forster, S. C., Bracken, C. P., & Gantier, M. P. (2021). Making use of transcription factor enrichment to identify functional microRNA-regulons. Computational and Structural Biotechnology Journal, 19, 4896-4903. DOI Scopus4 WoS4 Europe PMC4 |
| 2021 |
Wajahat, M., Bracken, C. P., & Orang, A. (2021). Emerging functions for snornas and snorna‐derived fragments. International Journal of Molecular Sciences, 22(19), 10193-1-10193-19. DOI Scopus108 WoS101 Europe PMC90 |
| 2020 |
Saunders, K., Bert, A. G., Dredge, B. K., Toubia, J., Gregory, P. A., Pillman, K. A., . . . Bracken, C. P. (2020). Insufficiently complex unique-molecular identifiers (UMIs) distort small RNA sequencing. Scientific Reports, 10(1), 1-9. DOI Scopus13 WoS11 Europe PMC9 |
| 2020 |
Pham, V. V. H., Liu, L., Bracken, C. P., Goodall, G. J., Li, J., & Le, T. D. (2020). DriverGroup: a novel method for identifying driver gene groups. Bioinformatics, 36(Supplement_2), i583-i591. DOI Scopus6 WoS7 Europe PMC4 |
| 2019 |
Pillman, K. A., Scheer, K. G., Hackett-Jones, E., Saunders, K., Bert, A. G., Toubia, J., . . . Bracken, C. P. (2019). Extensive transcriptional responses are co-ordinated by microRNAs as revealed by Exon-Intron Split Analysis (EISA). Nucleic Acids Research, 47(16), 14 pages. DOI Scopus8 WoS7 Europe PMC9 |
| 2019 |
Pham, V. V. H., Liu, L., Bracken, C. P., Goodall, G. J., Long, Q., Li, J., & Le, T. D. (2019). CBNA: a control theory based method for identifying coding and non-coding cancer drivers. PLoS computational biology, 15(12), e1007538. DOI Scopus29 WoS30 Europe PMC19 |
| 2019 |
Pillman, K. A., Goodall, G. J., Bracken, C. P., & Gantier, M. P. (2019). miRNA length variation during macrophage stimulation confounds the interpretation of results: implications for miRNA quantification by RT-qPCR. RNA, 25(2), 232-238. DOI Scopus16 WoS16 Europe PMC17 |
| 2018 |
Nejad, C., Pillman, K., Siddle, K., Pépin, G., Anko, M., McCoy, C., . . . Gantier, M. (2018). miR-222 isoforms are differentially regulated by type-I interferon. RNA, 24(3), 332-341. DOI Scopus30 WoS28 Europe PMC30 |
| 2018 |
Narayan, N., Bracken, C., & Ekert, P. (2018). MicroRNA-155 expression and function in AML: An evolving paradigm. Experimental Hematology, 62, 1-6. DOI Scopus32 WoS28 Europe PMC28 |
| 2018 |
Pillman, K. A., Phillips, C. A., Roslan, S., Toubia, J., Dredge, B. K., Bert, A. G., . . . Gregory, P. A. (2018). miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. EMBO Journal, 37(13), 20 pages. DOI Scopus90 WoS89 Europe PMC79 |
| 2018 |
Cursons, J., Pillman, K. A., Scheer, K. G., Gregory, P. A., Foroutan, M., Hediyeh-Zadeh, S., . . . Davis, M. J. (2018). Combinatorial targeting by MicroRNAs co-ordinates post-transcriptional control of EMT. Cell Systems, 7(1), 77-91. DOI Scopus75 WoS70 Europe PMC75 |
| 2017 |
Siira, S., Shearwood, A., Bracken, C., Rackham, O., & Filipovska, A. (2017). Defects in RNA metabolism in mitochondrial disease. International Journal of Biochemistry and Cell Biology, 85, 106-113. DOI Scopus7 WoS7 Europe PMC7 |
| 2017 |
Yu, F., Pillman, K., Neilsen, C., Toubia, J., Lawrence, D., Tsykin, A., . . . Bracken, C. (2017). Naturally existing isoforms of miR-222 have distinct functions. Nucleic Acids Research, 45(19), 11371-11385. DOI Scopus63 WoS59 Europe PMC59 |
| 2016 |
Bracken, C., Scott, H., & Goodall, G. (2016). A network-biology perspective of microRNA function and dysfunction in cancer. Nature Reviews Genetics, 17(12), 719-732. DOI Scopus606 WoS577 Europe PMC496 |
| 2015 |
Yu, F., Bracken, C., Pillman, K., Lawrence, D., Goodall, G., Callen, D., & Neilsen, P. (2015). p53 represses the oncogenic Sno-MiR-28 derived from a SnoRNA. PLoS One, 10(6), e0129190-1-e0129190-20. DOI Scopus64 WoS60 Europe PMC54 |
| 2015 |
Bracken, C., Khew-Goodall, Y., & Goodall, G. (2015). Network-based approaches to understand the roles of miR-200 and other micrornas in cancer. Cancer Research, 75(13), 2594-2599. DOI Scopus51 WoS50 Europe PMC47 |
| 2015 |
Thomson, D., Pillman, K., Anderson, M., Lawrence, D., Toubia, J., Goodall, G., & Bracken, C. (2015). Assessing the gene regulatory properties of Argonaute-bound small RNAs of diverse genomic origin. Nucleic Acids Research, 43(1), 470-481. DOI Scopus37 WoS36 Europe PMC38 |
| 2015 |
Cursons, J., Leuchowius, K., Waltham, M., Tomaskovic-Crook, E., Foroutan, M., Bracken, C., . . . Thompson, E. (2015). Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines. Cell Communication and Signaling, 13(1), 26-1-26-21. DOI Scopus48 WoS46 Europe PMC45 |
| 2014 |
Salmanidis, M., Pillman, K., Goodall, G., & Bracken, C. (2014). Direct transcriptional regulation by nuclear microRNAs. The International Journal of Biochemistry & Cell Biology, 54, 304-311. DOI Scopus69 WoS59 Europe PMC60 |
| 2014 |
Li, X., Roslan, S., Johnstone, C., Wright, J., Bracken, C., Anderson, M., . . . Khew-Goodall, Y. (2014). MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways. Oncogene, 33(31), 4077-4088. DOI Scopus109 WoS103 Europe PMC102 |
| 2014 |
Bracken, C. P., Li, X., Wright, J. A., Lawrence, D., Pillman, K. A., Salmanidis, M., . . . Goodall, G. (2014). Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. The EMBO Journal, 33(18), 1979-2134. DOI Scopus124 WoS121 Europe PMC115 |
| 2013 |
Thomson, D., Bracken, C., Szubert, J., & Goodall, G. (2013). On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PLoS One, 8(1), 1-10. DOI Scopus105 WoS103 Europe PMC99 |
| 2013 |
Neilsen, P., Noll, J., Mattiske, S., Bracken, C., Gregory, P., Schulz, R., . . . Callen, D. (2013). Mutant p53 drives invasion in breast tumors through up-regulation of miR-155. Oncogene, 32(24), 2992-3000. DOI Scopus154 WoS143 Europe PMC137 |
| 2012 |
Neilsen, C., Goodall, G., & Bracken, C. (2012). IsomiRs - the overlooked repertoire in the dynamic microRNAome. Trends in Genetics, 28(11), 544-549. DOI Scopus405 WoS381 Europe PMC365 |
| 2011 |
Thomson, D., Bracken, C., & Goodall, G. (2011). Experimental strategies for microRNA target identification. Nucleic Acids Research, 39(16), 6845-6853. DOI Scopus482 WoS453 Europe PMC418 |
| 2011 |
Bracken, C., Szubert, J., Mercer, T., Dinger, M., Thomson, D., Mattick, J., . . . Goodall, G. (2011). Global analysis of the mammalian RNA degradome reveals widespread miRNA-dependent and miRNA-independent endonucleolytic cleavage. Nucleic Acids Research, 39(13), 5658-5668. DOI Scopus71 WoS68 Europe PMC71 |
| 2011 |
Gregory, P., Bracken, C., Smith, E., Bert, A., Wright, J., Roslan, S., . . . Goodall, G. (2011). An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Molecular Biology of the Cell, 22(10), 1686-1698. DOI Scopus510 WoS478 Europe PMC464 |
| 2011 |
Mercer, T., Neph, S., Dinger, M., Crawford, J., Smith, M., Shearwood, A., . . . Mattick, J. (2011). The human mitochondrial transcriptome. Cell, 146(4), 645-658. DOI Scopus721 WoS680 Europe PMC659 |
| 2010 |
Mercer, T., Dinger, M., Bracken, C., Kolle, G., Szubert, J., Korbie, D., . . . Mattick, J. (2010). Regulated post-transcriptional RNA cleavage diversifies the eukaryotic transcriptome. Genome Research, 20(12), 1639-1650. DOI Scopus77 WoS66 Europe PMC73 |
| 2010 |
Tam, K., Russell, D., Peet, D., Bracken, C., Rodgers, R., Thompson, J., & Kind, K. (2010). Hormonally regulated follicle differentiation and luteinization in the mouse is associated with hypoxia inducible factor activity. Molecular and Cellular Endocrinology, 327(1-2), 47-55. DOI Scopus44 WoS42 Europe PMC36 |
| 2009 |
Bracken, C., Gregory, P., Khew-Goodall, Y., & Goodall, G. (2009). The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cellular and Molecular Life Sciences, 66(10), 1682-1699. DOI Scopus107 WoS96 Europe PMC90 |
| 2008 |
Gregory, P., Bracken, C., Bert, A., & Goodall, G. (2008). MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle, 7(20), 3112-3117. DOI Scopus449 WoS413 Europe PMC380 |
| 2008 |
Bracken, C., Gregory, P., Kolesnikoff, N., Bert, A., Wang, J., Shannon, M., & Goodall, G. (2008). A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Research, 68(19), 7846-7854. DOI Scopus959 WoS908 Europe PMC856 |
| 2008 |
Bracken, C., Wall, S., Barre, B., Panov, K., Ajuh, P., & Perkins, N. (2008). Regulation of cyclin D1 RNA stability by SNIP1. Cancer Research, 68(18), 7621-7628. DOI Scopus83 Europe PMC79 |
| 2007 |
Roche, K. C., Rocha, S., Bracken, C. P., & Perkins, N. D. (2007). Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1. Oncogene, 26(31), 4523-4530. DOI Scopus16 Europe PMC16 |
| 2006 |
Fujii, M., Lyakh, L. A., Bracken, C. P., Fukuoka, J., Hayakawa, M., Tsukiyama, T., . . . Roberts, A. B. (2006). SNIP1 Is a Candidate Modifier of the Transcriptional Activity of c-Myc on E Box-Dependent Target Genes. Molecular Cell, 24(5), 771-783. DOI Scopus56 Europe PMC54 |
| 2006 |
Bracken, C., Fedele, A., Karttunen, S., Balrak, W., Lisy, K., Whitelaw, M., & Peet, D. (2006). Cell-specific regulation of hypoxia-inducible factor (HIF)-1α and HIF-2α stabilization and transactivation in a graded oxygen environment. Journal of Biological Chemistry, 281(32), 22575-22585. DOI Scopus191 WoS188 Europe PMC171 |
| 2005 |
Bracken, C., Whitelaw, M., & Peet, D. (2005). Activity of hypoxia-inducible factor 2α is regulated by association with the NF-κB essential modulator. Journal of Biological Chemistry, 280(14), 14240-14251. DOI Scopus62 WoS60 Europe PMC55 |
| 2003 |
Bracken, C., Whitelaw, M., & Peet, D. (2003). The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses. Cellular and Molecular Life Sciences, 60(7), 1376-1393. DOI Scopus224 WoS206 Europe PMC186 |